Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Vikram David Durairaj, MD, FACS
Healthcare Professional Director
Oculofacial Plastic and Reconstructive Surgery
Even-Year Fellowship
TOC Eye and Face
3705 Medical Parkway, Suite 120
Austin, Texas, United States
Dr. Vikram David Durairaj is a board certified ophthalmologist and Program Director for the oculofacial plastic and reconstructive surgery even-year fellowship position at TOC Eye and Face. He graduated from Trinity University with a degree in biology and a minor in biophysics. He then completed his internship at Georgetown University and his residency at the University of Colorado. He also completed his 2-year American Society of Ophthalmic Plastic and Reconstructive Surgery fellowship at the Mayo Clinic, Rochester, Minnesota.
Dr. Durairaj takes his fiduciary role very seriously. His dedication to uncompromising care is demonstrated in his pristine record and excellent standing with the Texas Medical Board. He has performed more than 10,000 eyelid, orbit and lacrimal surgeries. Before joining TOC Eye and Face, Dr. Durairaj was a Professor of ophthalmology and otolaryngology – head and neck surgery at the University of Colorado School of Medicine. He served as the Director of the Ophthalmology Residency Program and Director of the American Society of Ophthalmic Plastic and Reconstructive Surgery fellowship at the University of Colorado.
Dr. Durairaj has given over 300 invited national and international lectures and courses, published over 150 peer-reviewed manuscripts, chapters, and abstracts, and presented his research at national and international meetings.
Representative publications:
Clinical Features and Treatment of Graves Ophthalmopathy in Pediatric Patients
Medical Management of Thyroid Eye Disease
Clinical Perspectives of Thyroid Eye Disease
Related Content
-
What Is Thyroid Eye Disease (TED)?https://www.youtube.com/watch?v=OVUZcQWF...
-
New Data from Phase 3 Teprotumumab Trial Shows Dramatic Reduction in Proptosis, or Eye Bulging, the Main Cause of Mo...Horizon Pharma plc today announced that ...
-
Lynn K. Gordon, MDLynn K. Gordon is a Professor of Ophthal...
-
Fatemeh Rajaii, MD, PhDFatemeh Rajaii is an Assistant Professor...
-
Risk Factors For Developing Thyroid-Associated Ophthalmopathy Among Individuals with Graves’ DiseaseImportance: Thyroid-associated ophthalm...
-
Efficacy of Orbital Radiotherapy in Moderate-to-Severe Active Graves’ Orbitopathy Including Long-Lasting Disease: ...Background: We aimed to explore the eff...
-
Shannon S. Joseph, MD, MScDr. Shannon S. Joseph is a board-certifi...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.